Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 18:12:e53652.
doi: 10.2196/53652.

Acceptability, Effectiveness, and Roles of mHealth Applications in Supporting Cancer Pain Self-Management: Integrative Review

Weizi Wu  1 , Teresa Graziano  1 , Andrew Salner  2 , Ming-Hui Chen  3 , Michelle P Judge  1 , Xiaomei Cong  4 , Wanli Xu  1
Affiliations
Review

Acceptability, Effectiveness, and Roles of mHealth Applications in Supporting Cancer Pain Self-Management: Integrative Review

Weizi Wu et al. JMIR Mhealth Uhealth. .

Abstract

Background: Cancer pain remains highly prevalent and persistent throughout survivorship, and it is crucial to investigate the potential of leveraging the advanced features of mobile health (mHealth) apps to empower individuals to self-manage their pain.

Objective: This review aims to comprehensively understand the acceptability, users' experiences, and effectiveness of mHealth apps in supporting cancer pain self-management.

Methods: We conducted an integrative review following Souza and Whittemore and Knafl's 6 review processes. Literature was searched in PubMed, Scopus, CINAHL Plus with Full Text, PsycINFO, and Embase, from 2013 to 2023. Keywords including "cancer patients," "pain," "self-management," "mHealth applications," and relevant synonyms were used in the search. The Johns Hopkins research evidence appraisal tool was used to evaluate the quality of eligible studies. A narrative synthesis was conducted to analyze the extracted data.

Results: A total of 20 studies were included, with the overall quality rated as high (n=15) to good (n=5). Using mHealth apps to monitor and manage pain was acceptable for most patients with cancer. The internal consistency of the mHealth in measuring pain was 0.96. The reported daily assessment or engagement rate ranged from 61.9% to 76.8%. All mHealth apps were designed for multimodal interventions. Participants generally had positive experiences using pain apps, rating them as enjoyable and user-friendly. In addition, 6 studies reported significant improvements in health outcomes, including enhancement in pain remission (severity and intensity), medication adherence, and a reduced frequency of breakthrough pain. The most frequently highlighted roles of mHealth apps included pain monitoring, tracking, reminders, education facilitation, and support coordination.

Conclusions: mHealth apps are effective and acceptable in supporting pain self-management. They offer a promising multi-model approach for patients to monitor, track, and manage their pain. These findings provide evidence-based insights for leveraging mHealth apps to support cancer pain self-management. More high-quality studies are needed to examine the effectiveness of digital technology-based interventions for cancer pain self-management and to identify the facilitators and barriers to their implementation in real-world practice.

Keywords: cancer pain; cancer survivors; integrative review; mHealth applications; self-management.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
The PRISMA flow diagram. This figure provides the details of (1) identification source (the database searches and reference tracking), (2) the stepwise screening of 281 records (initial screening and abstract, title, and full text), and (3) included 20 records in the review. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
See this image and copyright information in PMC

References

    1. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–436. doi: 10.3322/caac.21731. https://onlinelibrary.wiley.com/doi/10.3322/caac.21731 - DOI - DOI - PubMed
    1. Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1304–1312. doi: 10.1158/1055-9965.EPI-19-1534. https://europepmc.org/abstract/MED/32522832 1055-9965.EPI-19-1534 - DOI - PMC - PubMed
    1. Evenepoel M, Haenen V, De Baerdemaecker T, Meeus M, Devoogdt N, Dams L, Van Dijck S, Van der Gucht E, De Groef A. Pain prevalence during cancer treatment: a systematic review and meta-analysis. J Pain Symptom Manage. 2022;63(3):e317–e335. doi: 10.1016/j.jpainsymman.2021.09.011.S0885-3924(21)00533-9 - DOI - PubMed
    1. Börjeson S, Starkhammar H, Unosson M, Berterö C. Common symptoms and distress experienced among patients with colorectal cancer: a qualitative part of mixed method design. Open Nurs J. 2012;6:100–107. doi: 10.2174/1874434601206010100. https://europepmc.org/abstract/MED/22977653 TONURSJ-6-100 - DOI - PMC - PubMed
    1. Jones D, Zhao F, Brell J, Lewis MA, Loprinzi CL, Weiss M, Fisch MJ. Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer. J Cancer Surviv. 2015;9(1):1–10. doi: 10.1007/s11764-014-0379-x. https://europepmc.org/abstract/MED/25023039 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources